Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
3.91
Oct 23 • 4:00 PM ET Dollar change-0.17 Percentage change(-4.17%)
Aftermarket Close
3.92
Aftermarket • 7:57 PM ET Dollar change+0.01 Percentage change(0.26%)
Category
US Equities - Factor & Thematic
Sponsor
Advisor Shares
Fund Family
Index
-
Index Weighting
Active/Passive
Expense
0.78%
Inverse/Leveraged
IPO
Sep 02, 2020
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
Yes / Yes
Tags
Tags
Tags
Tags
-
Tags
-
Tags
-
Tags
-
Sector/Theme
Region
SMA20
-9.14%
SMA50
-16.46%
SMA200
-12.48%
Return% 1Y
-11.94%
Return% 3Y
-16.76%
Return% 5Y
-32.84%
Return% 10Y
Return% SI
Flows% 1M
-6.50%
Flows% 3M
-9.72%
Flows% YTD
-6.74%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
25
AUM
725.75M
NAV/sh
52W High
7.25 -46.07%
52W Low
2.96 32.09%
Volatility
6.15% 4.99%
ATR (14)
0.23
RSI (14)
35.10
Beta
1.53
Rel Volume
1.03
Avg Volume
4.74M
Volume
4,901,614
Perf Week
0.51%
Perf Month
-24.52%
Perf Quarter
-7.78%
Perf Half Y
-16.45%
Perf YTD
-17.16%
Perf Year
-16.63%
Perf 3Y
-39.75%
Perf 5Y
-86.24%
Perf 10Y
-
Prev Close
4.08
Price
3.91
Change %
-4.17%
AdvisorShares Pure US Cannabis ETF seeks long-term capital appreciation. The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.